NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes
NASDAQ:NCEL|Bullish|9 Mar 2026 · 5 days ago
Read More →Want to know each day's companies with the most bullish news?
1 article · filtered by NCEL